comprehensive -WSS

comprehensive

author：fashion 2025-09-28 21:06:56 - browse：33

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： There’s no way to know how good AI health technologies are

explore

WSS

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

5 ways to address the shortage of health care workers

Better Therapeutics data on benefit with GLP

Readout Newsletter: Beam, Prozac, "TechBio" and more

Children’s Hospital revives plan for pedestrian bridge

Life sciences deals on track to hit lowest point since 2017

hotspot

comprehensive

entertainment

Activists slam private health insurers over coverage restrictions

Medicare Advantage isn’t working — for anyone

The cancer drug shortage isn’t new — and neither are the solutions

Using force crossed my mind when examining a defiant young patient

Trump demands the U.S. pay no more for drugs than other countries … again

5 ways to address the shortage of health care workers

Heart attack and stroke risk calculators need revising

Are embryos people? Reproductive medicine's future depends on the answer

Walensky prepares to leave CDC — and Congress — behind

Medicare isn't yet testing food as medicine

focus

Virtual repurposing can help discover new uses for existing drugs

Medicare Advantage isn’t working — for anyone

Children’s Hospital revives plan for pedestrian bridge

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

STAT Readout: Today's biotech news includes Sana and Amylyx

Children’s Hospital revives plan for pedestrian bridge

leisure time

focus

explore

hotspot